Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-Jan-23 4:57 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 1,412 | $52.05 | $73,494.60 | (6%) 24.97K to 23.56K | |
| 28-Oct-22 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 26-Oct-22 | Payment of Exercise | 130 | $58.41 | $7,593.30 | (< 1%) 24.97K to 24.84K | |
| 22-Jun-22 4:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Jun-22 | Market Sale | 2,698 | $45.00 | $121,410.00 | (10%) 27.67K to 24.97K | 1% |
| 29-Mar-22 4:12 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Mar-22 | Payment of Exercise | 82 | $49.28 | $4,040.96 | (< 1%) 28.41K to 28.32K | |
| 14-Feb-22 10:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-22 | Payment of Exercise | 175 | $47.12 | $8,246.00 | (< 1%) 28.58K to 28.41K | |
| 01-Feb-22 6:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 434 | $38.59 | $16,748.10 | (1%) 29.02K to 28.58K | (15%) |
| 25-Jan-22 4:39 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 17,466 | -- | -- | 151% 11.55K to 29.02K | |
| 27-Oct-21 4:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 26-Oct-21 | Grant | 882 | -- | -- | 8% 10.54K to 11.42K | |
| 29-Mar-21 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Mar-21 | Payment of Exercise | 82 | $41.16 | $3,375.12 | (< 1%) 10.03K to 9.95K | (38%) |
| 19-Mar-21 5:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-21 | Grant | 1,250 | -- | -- | 14% 8.78K to 10.03K | |
| 11-Feb-21 4:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-21 | Payment of Exercise | 144 | $47.72 | $6,871.68 | (2%) 8.93K to 8.78K | (19%) |
| 01-Feb-21 4:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 5,000 | -- | -- | 127% 3.93K to 8.93K | |
| 09-Oct-20 4:45 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 07-Oct-20 | Option Exercise | 12,000 | $18.98 | $227,760.00 | 333% 3.61K to 15.61K | |
| 09-Oct-20 4:45 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 07-Oct-20 | Market Option Sale | 12,000 | $35.00 | $420,000.00 | (77%) 15.61K to 3.61K | (62%) |